SCHEMBL18735896

SCHEMBL18735896

Cc1ccc(/C=N/c2cc([N+](=O)[O-])ccc2O)cc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 1/20 0.74
▸ MAOA P21397 1/20 0.57
▸ MAOB P27338 1/20 0.57
▸ G6PD P11413 1/20 0.57
▸ MAPT P10636 6/20 0.52
▸ KDM4E B2RXH2 6/20 0.52
▸ ALDH1A1 P00352 6/20 0.52
▸ MEN1 O00255 4/20 0.52
▸ KMT2A Q03164 4/20 0.52
▸ HTT P42858 4/20 0.52
▸ SMN1; SMN2 Q16637 3/20 0.52
▸ HPGD P15428 2/20 0.52
▸ PSMD14 O00487 1/20 0.52
▸ PKM P14618 1/20 0.49
▸ LMNA P02545 4/20 0.47
▸ POLB P06746 3/20 0.47
▸ NFE2L2 Q16236 1/20 0.47
▸ ACHE P22303 1/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ RECQL P46063 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22749158 0.89 CDK2 (0.74) CDK2MAOAMAOBG6PDMAPT
SCHEMBL18735897 0.87 CDK2 (0.57) CDK2MAOAMAOBG6PDMAPT
SCHEMBL9833864 0.86 CDK2 (0.70) CDK2MAOAMAOBG6PDMAPT
SCHEMBL9833860 0.86 CDK2 (0.70) CDK2MAOAMAOBG6PDMAPT
SCHEMBL22624828 0.83 CDK2 (0.56) CDK2MAOAMAOBMAPTKDM4E
SCHEMBL14337523 0.78 G6PD (0.60) CDK2MAOBG6PDMAPTKDM4E
SCHEMBL11718823 0.77 MAPT (0.58) CDK2MAOAMAOBG6PDMAPT
SCHEMBL11718830 0.77 MAPT (0.58) CDK2MAOAMAOBG6PDMAPT
SCHEMBL9176249 0.77 G6PD (0.60) CDK2MAOBG6PDMAPTKDM4E
SCHEMBL9173534 0.77 ALDH1A1 (0.67) CDK2MAOBG6PDMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170100414-A1 SMALL MOLECULE EFFLUX PUMP INHIBITORS UNIVERSITY OF ROCHESTER (US) 2017-04-13 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170100414-A1 SMALL MOLECULE EFFLUX PUMP INHIBITORS ABCB11, ABCB1, ABCC1 CDK2 4648/4885MAOA 3340/4885MAOB 3014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback